Previous studies have shown that ET-1, in addition to being a potent vasoconstrictor, may induce endothelial dysfunction by decreasing NO bioavailability and is one of the biomarkers of endothelial dysfunction [11]. This evidence concerns the gene EDN1 and endothelial dysfunction.